Monitor Q4 2026 for initial order revenue and potential expansion into additional international markets. The deal provides a proof-of-concept for Microbot's international distribution strategy but lacks disclosed financial terms, limiting near-term valuation impact.
Price Chart
Executive Summary
Microbot Medical signed a three-year exclusive distribution agreement with Medtechnica Ltd. for its LIBERTY Endovascular Robotic System in Israel, following May 2026 regulatory approval from the Israeli Ministry of Health. Initial orders are anticipated in Q4 2026, marking the company's first international commercial distribution deal outside the U.S.
Key Facts
- Three-year exclusive commercial distribution agreement with Medtechnica Ltd. for the LIBERTY System in Israel.
- Israeli Ministry of Health (AMAR) regulatory approval received in May 2026.
- Initial orders anticipated in Q4 2026.
- LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Financial Impact
No financial terms disclosed; initial orders expected in Q4 2026.
Risk Factors
- No disclosed minimum order quantities or financial guarantees from Medtechnica.
- Geopolitical risks in Israel due to ongoing regional hostilities.
- Dependence on single distributor for Israeli market entry.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3375487 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $0.9400 (−3.48%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9400 (−0.79%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9400 (−12.15%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9400 (−12.15%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9400 (−24.80%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9400 (−44.05%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9400 (−47.78%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9400 (−50.53%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9400 (−51.79%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9400 (−48.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers